|
WO2020058767A1
|
|
Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones
|
|
WO2019171174A2
|
|
Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
|
|
WO2018047002A1
|
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1.2-dithiole-3-thione, taste-modified formulations, and methods of making and using same
|
|
BR112019004639A2
|
|
4-methyl-5- (pyrazin-2-yl) -3h-1,2-dithiol-3-thione formulations, taste-modified formulations and methods for producing and using them
|
|
WO2018047013A1
|
|
Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
|
|
CN109996562A
|
|
The preparation and its preparation and application of 4- methyl -5- (pyrazine -2- base) -3H-1,2- dithiole -3- thioketones
|
|
WO2016207914A2
|
|
Methods for preparing oltipraz
|
|
AU2016308080A1
|
|
Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
|
|
US2016376259A1
|
|
Methods for Preparing Oltipraz
|
